Back to Search
Start Over
Future therapies: Early trials and basic science
- Source :
- Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 7(9-10 Suppl 4)
- Publication Year :
- 2014
-
Abstract
- Pharmacotherapeutic options for overactive bladder (OAB) include antimuscarinics and the beta3-adrenoceptor (AR) agonist mirabegron. Research and development of novel therapeutic options for OAB continues to be an active field. This review summarizes recent research with the existing therapies as well as the most promising agents in development.
- Subjects :
- medicine.medical_specialty
Section 2: Treatment Considerations for OAB-Review
business.industry
Basic science
Urology
Pharmacology
medicine.disease
urologic and male genital diseases
humanities
female genital diseases and pregnancy complications
Oncology
Overactive bladder
Medicine
business
Mirabegron
Intensive care medicine
medicine.drug
Subjects
Details
- ISSN :
- 19116470
- Volume :
- 7
- Issue :
- 9-10 Suppl 4
- Database :
- OpenAIRE
- Journal :
- Canadian Urological Association journal = Journal de l'Association des urologues du Canada
- Accession number :
- edsair.doi.dedup.....a2cf23ca43d4588bce53a9b4dd174174